HS-10509
- Generic Name
- HS-10509
The Phase I Study of HS-10509 in Chinese Adult Subjects
- First Posted Date
- 2024-03-08
- Last Posted Date
- 2024-03-08
- Lead Sponsor
- Jiangsu Hansoh Pharmaceutical Co., Ltd.
- Target Recruit Count
- 80
- Registration Number
- NCT06301074
- Locations
- 🇨🇳
The First Hospital of Jilin University, Changchun, Jilin, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath